Release form
Ointment for external use.
Packaging
Tube 10 g.
Pharmacological action
Immunomodulating and antiviral drug. Human recombinant interferon alpha - 2 has pronounced antiviral, antiproliferative and immunomodulating properties. In the presence of excipients that are part of the preparation (antioxidant tocopherol acetate), the specific antiviral activity of interferon human recombinant alpha-2 increases, its immunomodulatory effect is enhanced (stimulation of the phagocytic function of neutrophils in the lesion foci).
For topical and topical use, systemic absorption of interferon is low.
Indications
For the treatment of herpetic infections (Herpes simplex type 1 and 2) of the skin and mucous membranes of various localization.
As part of the complex treatment of influenza and other acute respiratory viral infections in children aged 1 year.
Contraindications
Individual intolerance to the components of the drug.
Children's age up to 1 year.
Use during pregnancy and lactation
Since external and local application of systemic absorption of interferon is low and the drug acts only in the lesion, it is possible to use the drug VIFERON, ointment during pregnancy and lactation.
Composition
1 g of ointment for external and local use contains the active substance: interferon alfa-2 human recombinant 40,000 IU excipients: tocopherol acetate 0.02 g, anhydrous lanolin 0.34 g, medical petrolatum 0.45 g, peach oil 0.12 g, purified water to 1.0 g.
Dosage and administration
Viferon ointment is applied with a thin layer on the lesions 3-4 times a day, the duration of treatment is 5-7 days.
It is recommended to start treatment immediately when the first signs of damage to the skin and mucous membranes appear (itching, burning, redness). When treating recurrent herpes, it is advisable to begin treatment in the prodromal period or at the very beginning of the appearance of signs of relapse.
For the treatment of influenza and other acute respiratory viral infections, an ointment is applied with a thin layer on the mucous membrane of the nasal passages 3-4 times a day:
for children from 1 year to 2 years 2500 IU (1 pea in diameter 0.5 cm) 3 times a day for
children from 2 to 12 years 2500 IU (1 pea with a diameter of 0.5 cm) 4 times a day
for children from 12 to 18 years 5000 IU (1 pea with a diameter of 1 cm) 4 times a day.
Duration of treatment is 5 days.
Side effects
In most cases, the drug VIFERON, ointment for external and local use is well tolerated. When applied to the nasal mucosa, side effects (rhinorrhea, sneezing, burning of the nasal mucosa) are weak and transient in nature and disappear on their own after discontinuation of the drug.
Drug Interactions
Drug VIFERON, ointment for external and local use, compatible and well combined with all drugs used in the treatment of acute respiratory viral infections, including influenza, viral (herpetic) lesions of the skin and mucous membranes.
Storage conditions
At 2–8 РC.
Keep out of the reach of children.
Expiration
1 year. Do not use the drug after the expiry date.
The opened aluminum tube is stored in the refrigerator for 1 month.
Store exposed polystyrene jar in the refrigerator for no more than 14 days.
Deystvuyuschee substances
interferon alfa-2b
Terms
pharmacy leave without a prescription
Form of Treatment
mazy
Indications
Prevention hryppa, Hrypp, acute respiratory viral infections, herpes
Fearon, Russia
Ointment for external use.
Packaging
Tube 10 g.
Pharmacological action
Immunomodulating and antiviral drug. Human recombinant interferon alpha - 2 has pronounced antiviral, antiproliferative and immunomodulating properties. In the presence of excipients that are part of the preparation (antioxidant tocopherol acetate), the specific antiviral activity of interferon human recombinant alpha-2 increases, its immunomodulatory effect is enhanced (stimulation of the phagocytic function of neutrophils in the lesion foci).
For topical and topical use, systemic absorption of interferon is low.
Indications
For the treatment of herpetic infections (Herpes simplex type 1 and 2) of the skin and mucous membranes of various localization.
As part of the complex treatment of influenza and other acute respiratory viral infections in children aged 1 year.
Contraindications
Individual intolerance to the components of the drug.
Children's age up to 1 year.
Use during pregnancy and lactation
Since external and local application of systemic absorption of interferon is low and the drug acts only in the lesion, it is possible to use the drug VIFERON, ointment during pregnancy and lactation.
Composition
1 g of ointment for external and local use contains the active substance: interferon alfa-2 human recombinant 40,000 IU excipients: tocopherol acetate 0.02 g, anhydrous lanolin 0.34 g, medical petrolatum 0.45 g, peach oil 0.12 g, purified water to 1.0 g.
Dosage and administration
Viferon ointment is applied with a thin layer on the lesions 3-4 times a day, the duration of treatment is 5-7 days.
It is recommended to start treatment immediately when the first signs of damage to the skin and mucous membranes appear (itching, burning, redness). When treating recurrent herpes, it is advisable to begin treatment in the prodromal period or at the very beginning of the appearance of signs of relapse.
For the treatment of influenza and other acute respiratory viral infections, an ointment is applied with a thin layer on the mucous membrane of the nasal passages 3-4 times a day:
for children from 1 year to 2 years 2500 IU (1 pea in diameter 0.5 cm) 3 times a day for
children from 2 to 12 years 2500 IU (1 pea with a diameter of 0.5 cm) 4 times a day
for children from 12 to 18 years 5000 IU (1 pea with a diameter of 1 cm) 4 times a day.
Duration of treatment is 5 days.
Side effects
In most cases, the drug VIFERON, ointment for external and local use is well tolerated. When applied to the nasal mucosa, side effects (rhinorrhea, sneezing, burning of the nasal mucosa) are weak and transient in nature and disappear on their own after discontinuation of the drug.
Drug Interactions
Drug VIFERON, ointment for external and local use, compatible and well combined with all drugs used in the treatment of acute respiratory viral infections, including influenza, viral (herpetic) lesions of the skin and mucous membranes.
Storage conditions
At 2–8 РC.
Keep out of the reach of children.
Expiration
1 year. Do not use the drug after the expiry date.
The opened aluminum tube is stored in the refrigerator for 1 month.
Store exposed polystyrene jar in the refrigerator for no more than 14 days.
Deystvuyuschee substances
interferon alfa-2b
Terms
pharmacy leave without a prescription
Form of Treatment
mazy
Indications
Prevention hryppa, Hrypp, acute respiratory viral infections, herpes
Fearon, Russia
Related Products
